<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03737266</url>
  </required_header>
  <id_info>
    <org_study_id>Seno_Ex_MAC 003</org_study_id>
    <nct_id>NCT03737266</nct_id>
  </id_info>
  <brief_title>Comparison of Conventional With Sonography Assisted Breast Surgery After Neoadjuvant Chemotherapy</brief_title>
  <official_title>Sonographically Assisted Versus Conventionally Breast Surgery in Breast Cancer Patients With an Indication for Breast Conserving Surgery After Neoadjuvant Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to investigate whether intra-surgical visualisation of malignoma reduces
      the resection rate in the case of R1 resection compared to the procedure without sonographic
      visualisation
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>R0 resection rate</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight of primary resedate</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for cut and sew</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Breast Cancer Surgery</condition>
  <arm_group>
    <arm_group_label>Sonographically assisted breast surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sonography assisted breast surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional breast surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional breast surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sonographically assisted breast surgery</intervention_name>
    <description>Sonography</description>
    <arm_group_label>Conventional breast surgery</arm_group_label>
    <arm_group_label>Sonographically assisted breast surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional breast surgery</intervention_name>
    <description>Conventional</description>
    <arm_group_label>Conventional breast surgery</arm_group_label>
    <arm_group_label>Sonographically assisted breast surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 80 years

          -  Female

          -  Presurgical validated breast cancer

          -  Unifocal to multifocal findings

          -  Palpable and/o non-palpable findings

          -  Neoadjuvant chemotherapy

          -  Indication for breast conserving therapy

          -  General operation ability and anesthesia ability

          -  Consent to conventional breast conserving breast surgery with wire marking

          -  Ability and will to follow the study conditions

          -  Written declaration of consent after clarification

        Exclusion Criteria:

          -  Sonographically not clearly delineate resection areal

          -  Exclusion criteria for breast conserving therapy

          -  Simultaneous participation in other interventional trials that interfere with this
             study at the investigator's discretion
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Markus Hahn, MD</last_name>
    <phone>004970712982211</phone>
    <email>markus.hahn@med.uni-tuebingen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department for Women's Health</name>
      <address>
        <city>TÃ¼bingen</city>
        <state>BW</state>
        <zip>72086</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Hahn, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 16, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2018</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

